117 related articles for article (PubMed ID: 31519601)
1. The Influence of Adjuvant Radiotherapy and Single Nucleotide Polymorphisms on Circulating Immune Response Cell Numbers and Phenotypes of Patients With Breast Cancer.
Lewin NL; Luetragoon T; Shamoun L; Oliva D; Andersson BÅ; Löfgren S; Rutqvist LE; Lewin F
Anticancer Res; 2019 Sep; 39(9):4957-4963. PubMed ID: 31519601
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Single Nucleotide Polymorphisms and Adjuvant Radiotherapy on Systemic Inflammatory Proteins, Chemokines and Cytokines of Patients With Breast Cancer.
Lewin NL; Luetragoon T; Andersson BÅ; Oliva D; Nilsson M; Strandeus M; Löfgren S; Rutqvist LE; Lewin F
Anticancer Res; 2019 Mar; 39(3):1287-1292. PubMed ID: 30842160
[TBL] [Abstract][Full Text] [Related]
3. Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients.
Janssen N; Fortis SP; Speigl L; Haritos C; Sotiriadou NN; Sofopoulos M; Arnogiannaki N; Stavropoulos-Giokas C; Dinou A; Perez S; Pawelec G; Baxevanis CN; Shipp C
Breast Cancer Res Treat; 2017 Jan; 161(1):51-62. PubMed ID: 27787640
[TBL] [Abstract][Full Text] [Related]
4. CD14+ HLA-DR-/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation.
Speigl L; Burow H; Bailur JK; Janssen N; Walter CB; Pawelec G; Shipp C
Breast Cancer Res Treat; 2018 Apr; 168(2):401-411. PubMed ID: 29230664
[TBL] [Abstract][Full Text] [Related]
5. Individual Genetic Variation Might Predict Acute Skin Reactions in Women Undergoing Adjuvant Breast Cancer Radiotherapy.
Oliva D; Nilsson M; Strandéus M; Andersson BÅ; Sharp L; Laytragoon-Lewin N; Lewin F
Anticancer Res; 2018 Dec; 38(12):6763-6770. PubMed ID: 30504388
[TBL] [Abstract][Full Text] [Related]
6. Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function.
Boniface JD; Poschke I; Mao Y; Kiessling R
Int J Cancer; 2012 Jul; 131(1):129-39. PubMed ID: 21823123
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients.
Sage EK; Schmid TE; Sedelmayr M; Gehrmann M; Geinitz H; Duma MN; Combs SE; Multhoff G
Radiother Oncol; 2016 Jan; 118(1):176-80. PubMed ID: 26683801
[TBL] [Abstract][Full Text] [Related]
8. Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer.
Datta J; Berk E; Xu S; Fitzpatrick E; Rosemblit C; Lowenfeld L; Goodman N; Lewis DA; Zhang PJ; Fisher C; Roses RE; DeMichele A; Czerniecki BJ
Breast Cancer Res; 2015 May; 17(1):71. PubMed ID: 25997452
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous detection of circulating immunological parameters and tumor biomarkers in early stage breast cancer patients during adjuvant chemotherapy.
Rovati B; Mariucci S; Delfanti S; Grasso D; Tinelli C; Torre C; De Amici M; Pedrazzoli P
Cell Oncol (Dordr); 2016 Jun; 39(3):211-28. PubMed ID: 26769126
[TBL] [Abstract][Full Text] [Related]
10. Impact of adjuvant chemo- and radiotherapy on the cellular immune system of breast cancer patients.
Mellios T; Ko HL; Beuth J
In Vivo; 2010; 24(2):227-30. PubMed ID: 20364000
[TBL] [Abstract][Full Text] [Related]
11. Integration of radiation and immunotherapy in breast cancer - Treatment implications.
Ye JC; Formenti SC
Breast; 2018 Apr; 38():66-74. PubMed ID: 29253718
[TBL] [Abstract][Full Text] [Related]
12. Immune defects in breast cancer patients after radiotherapy.
Standish LJ; Torkelson C; Hamill FA; Yim D; Hill-Force A; Fitzpatrick A; Olsen M; Schildt S; Sweet E; Wenner CA; Martzen MR
J Soc Integr Oncol; 2008; 6(3):110-21. PubMed ID: 19087768
[TBL] [Abstract][Full Text] [Related]
13. Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study.
Mozaffari F; Lindemalm C; Choudhury A; Granstam-Björneklett H; Lekander M; Nilsson B; Ojutkangas ML; Osterborg A; Bergkvist L; Mellstedt H
Cancer Immunol Immunother; 2009 Jan; 58(1):111-20. PubMed ID: 18488220
[TBL] [Abstract][Full Text] [Related]
14. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic Variants in Oxidative Stress Genes and Acute Toxicity in Breast Cancer Patients Receiving Radiotherapy.
Córdoba EE; Abba MC; Lacunza E; Fernánde E; Güerci AM
Cancer Res Treat; 2016 Jul; 48(3):948-54. PubMed ID: 26790968
[TBL] [Abstract][Full Text] [Related]
17. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
[TBL] [Abstract][Full Text] [Related]
18. Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.
Jacob S; Pathak A; Franck D; Latorzeff I; Jimenez G; Fondard O; Lapeyre M; Colombier D; Bruguiere E; Lairez O; Fontenel B; Milliat F; Tamarat R; Broggio D; Derreumaux S; Ducassou M; Ferrières J; Laurier D; Benderitter M; Bernier MO
Radiat Oncol; 2016 Apr; 11():54. PubMed ID: 27056179
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.
Azria D; Riou O; Castan F; Nguyen TD; Peignaux K; Lemanski C; Lagrange JL; Kirova Y; Lartigau E; Belkacemi Y; Bourgier C; Rivera S; Noël G; Clippe S; Mornex F; Hennequin C; Kramar A; Gourgou S; Pèlegrin A; Fenoglietto P; Ozsahin EM
EBioMedicine; 2015 Dec; 2(12):1965-73. PubMed ID: 26844275
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival.
Poleszczuk J; Luddy K; Chen L; Lee JK; Harrison LB; Czerniecki BJ; Soliman H; Enderling H
Breast Cancer Res; 2017 Jun; 19(1):75. PubMed ID: 28666457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
